AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.

Recruitingn/aAges 18 Years - 70 YearsAllPeking Union Medical College Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Primary liver cancer, mainly including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), represents the third leading cause of cancer-related mortality. Enhancing the precision of liver cancer diagnosis and providing early therapeutic efficacy and prognostic evaluation during clinical decision-making hold significant clinical importance. Ultrasound is the preferred imaging modality for liver cancer screening. Contrast-enhanced ultrasound (CEUS) can dynamically visualize the microvascular perfusion of liver cancer lesions. Liver elastography has become a commonly used clinical assessment tool for cirrhosis. Photoacoustic imaging (PAI), an emerging non-invasive functional imaging technique, enables visualization of specific molecules through their spectroscopic characteristics at designated wavelengths. The objectives of this study include: (1) Conducting an observ

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age \>18 and โ‰ค70 years; 2. Both sexes eligible; 3. Diagnosed with primary HCC or ICC; 4. Scheduled for surgical resection or conversion therapy; 5. Pathologically confirmed HCC/ICC via surgery or biopsy; 6. Posterior margin of the lesion โ‰ค 8 cm from the skin surface. Exclusion Criteria: 1. Pregnancy, lactation, or planned pregnancy during the study period; 2. History of other malignancies; 3. Cardiac, pulmonary, cerebral, or renal insufficiency; 4. Lesion depth \>8 cm from the skin surface on ultrasound; 5. Massive ascites; 6. Poor compliance (e.g., inability to hold breath during examination); 7. Allergy to ultrasound contrast agents.
๐Ÿ’Š

What it tests

  • Multi-modal ultrasonic imaging system for liver cancer
๐Ÿ“

Where

1 site
Peking Union Medical College Hospital
Beijing, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy